Join our interactive Lunch and Learn Seminar in San Diego this December. Register now to explore the latest developments in patient-derived and PDX-derived organoids for oncology drug discovery.
New advanced models are needed to improve preclinical predictivity and enhance oncology drug discovery. Tumor organoids, developed directly from patient or PDX tumors using exclusive Hubrecht Organoid Technology (HUB) protocols, are a new, clinically-relevant 3D in vitro system. Explore how organoids increase throughput, provide faster results, and help identify the most appropriate in vivo models.
During the seminar there’ll be a 50 minute presentation on ?Patient-Derived Experimental Models for Translational Cancer Research’. You?ll also have the chance to ask any questions related to your studies, as well as time to network with peers during a light lunch.
Reserve Your Seat Now
Attendance is free of charge, on a first come first serve basis, with registration for the event mandatory.
From Dec 11, 2019 11:00AM to Dec 11, 2019 01:00PM at Green Acre Campus Pointe ? Salon B, 10300 Campus Pointe Drive, San Diego, CA 92121